Clinicopathological Characteristics of Gastric Carcinoma in Young Patients
Overview
Affiliations
Background And Aims: Gastric carcinoma is a common disease that usually affects older patients, rarely younger patients. Although the relationship between prognosis and the age of patients with gastric carcinoma is controversial, most investigators have suggested that young patients have a poorer prognosis. This study examined the clinicopathological features of young patients with gastric carcinoma.
Patients And Methods: We retrospectively reviewed the hospital records of 1,833 patients with gastric carcinoma to compare the clinicopathological findings in young (aged <36 years) and older (aged >/= 36 years) patients during the period 1988 to 1998 in a tertiary referral center in Gwangju City. Overall survival was the main outcome measure.
Results: Of the 1,833 patients, 137 (7.5%) were in the young age group. There were no significant differences in depth of invasion, lymph node invasion, hepatic metastasis, peritoneal dissemination, tumor stage or rate of curative resection. A significantly higher percentage of young patients had poorly differentiated histology ( P=0.0001). The young patients with curatively resected gastric carcinoma had a better survival rate than young patients with non-resected gastric carcinoma ( P<0.001). The 5-year survival rates of young and older patients did not differ statistically (39.6% vs 42.4%; P=0.254).
Conclusion: Young patients with gastric carcinoma do not have a worse prognosis than older patients. The important prognostic factor was whether the patients underwent curative resection.
Kang K, Bagaoisan M, Zhang Y Cureus. 2024; 16(6):e62826.
PMID: 39036206 PMC: 11260356. DOI: 10.7759/cureus.62826.
Analysis of clinicopathologic characteristics and prognosis of gastric cancer in patients <40 years.
Liu L, Lin J, Zhao J, Yan P Medicine (Baltimore). 2023; 102(34):e34635.
PMID: 37653814 PMC: 10470719. DOI: 10.1097/MD.0000000000034635.
Kim Y, Jung Y, Park T, Jeong S, Kim T, Lee J JGH Open. 2023; 7(2):118-127.
PMID: 36852144 PMC: 9958344. DOI: 10.1002/jgh3.12860.
Kist M, Thomaschewski M, Keck Y, Abdalla T, Zeissig S, Tol K Cancers (Basel). 2022; 14(23).
PMID: 36497406 PMC: 9739447. DOI: 10.3390/cancers14235927.
Rijken A, Lurvink R, Luyer M, Nieuwenhuijzen G, van Erning F, van Sandick J J Clin Med. 2021; 10(21).
PMID: 34768402 PMC: 8584453. DOI: 10.3390/jcm10214882.